Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Total 13F shares
-
67,249,642
-
Share change
-
+1,240,247
-
Total reported value
-
$6,356,373,261
-
Put/Call ratio
-
42%
-
Price per share
-
$94.52
-
Number of holders
-
308
-
Value change
-
+$125,373,531
-
Number of buys
-
183
-
Number of sells
-
114
Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2017
As of 30 Jun 2017,
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,249,642 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., FRANKLIN RESOURCES INC, Neuberger Berman Group LLC, Select Equity Group, L.P., STATE STREET CORP, JPMORGAN CHASE & CO, BAMCO INC /NY/, and EAGLE ASSET MANAGEMENT INC.
This page lists
309
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.